购物车
您的购物车当前为空
别名 F-522, F522, DA 3031, DA 3023, DA 1701
F 522 (DA-3031) is a recombinant human granulocytic colony-stimulating factor that is expected to last longer than unmodified fegestine for the prevention of breast cancer. DA-3031 is a newly developed pegylated non - gostin.

F 522 (DA-3031) is a recombinant human granulocytic colony-stimulating factor that is expected to last longer than unmodified fegestine for the prevention of breast cancer. DA-3031 is a newly developed pegylated non - gostin.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 6-8周 | |
| 50 mg | ¥ 13,800 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 |
| 产品描述 | F 522 (DA-3031) is a recombinant human granulocytic colony-stimulating factor that is expected to last longer than unmodified fegestine for the prevention of breast cancer. DA-3031 is a newly developed pegylated non - gostin. |
| 别名 | F-522, F522, DA 3031, DA 3023, DA 1701 |
| 分子量 | 185.26 |
| 分子式 | C10H19NO2 |
| CAS No. | 25134-54-7 |
| Smiles | O=C(OCCN(C)C)C(=C)C.C=C |
| 密度 | 0.9301 g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多